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Consent in Jehovah’s Witnesses
Editor—Sydor and colleagues1 studied trainee behaviour in a
crisis situation, and trainee ability to challenge a decision by
a consultant anaesthetist to administer blood to a patient
who is a Jehovah’s Witness. This was described as unethical, al-
though perhaps a better term would be ‘in breach of the law’.
I would like to put it to the authors that unless the notes
were shown to contain the proper Advance Decision, the con-
sultant anaesthetist’s decision could have been ethical and
legal. In the UK, the legal position is that in the case of life-
sustaining treatment, the advance decision must be made by
an adult who has capacity, needs to be in writing, signed in
the presence of awitness, and it must include aclear statement
that the advance decision is to apply to the specific treatment
even if the decision maker’s life is at risk. If any of the above
conditions are not fulfilled, the doctor then must act in the
patient’s best interests. It is not clear from the scenario
whether such a form was included in the notes. ‘Consult’
done byatrainee on call overnight wasfairly brief, with no men-
tion of Advance Decision.
While it is important to respect the wishes of a Jehovah’s
Witness, it is also important to establish exactly what those
wishes are and whether they have a legal standing. The ethical







1 Sydor DT, Bould MD, Naik VN, et al. Challenging authority during a
life-threatening crisis: the effect of operating theatre hierarchy.
Br J Anaesth 2013; 110: 463–71
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Potential confounder in the ethical dilemma
of challenging authority
Editor—I read with interest the study by Sydor and colleagues1
examining the responses of trainee anaesthetists when faced
with the ‘unethical’ actions of a senior colleague in a simulated
clinical crisis. Being able to challenge colleagues when moti-
vated by the need to avert an adverse event is an important
non-technical skill, and study of the factors that influence this
ability is interesting and worthwhile. However, I note that the
unethical action the authors created at the centre of the simula-
tion was that of giving a blood transfusion to an anaesthetized
Jehovah’s Witness suffering a severe intraoperative haemor-
rhage with life-threatening features of cardiac ischaemia. I
wonder whether this represents a confounding factor in their
study. Although the authors cite legal precedent regarding
blood transfusion of a Jehovah’s Witness patient against their
express wishes, I would not agree that such an act is unambigu-
ously and consistently unethical. The bioethics concerning the
dominance of the principle of autonomy in refusal of blood trans-
fusion regardless of severe harm or death are not particularly
straightforward.2 Having professional experience of an intra-
operativedeathdue topost-partumhaemorrhage in aJehovah’s
Witness who refused blood and whose pre-existing wishes were
honoured, I can vouch that the option to give blood products in
an attempt to preserve life was hotly debated during the
events and for some time afterwards. The authors describe this
as ‘a clearly unethical decision’, which is at best overstated.
The authors express surprise at the omission and commission
of their subjects. However, the fact that many people will fail to
challenge and even actively participate in a definitely unethical
act under the influence of authority is well accepted3 and is
probably a part of normal human psychology. I suggest that
the study by Sydor and colleagues would have been stronger
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2 Muramoto O. Bioethics of the refusal of blood by Jehovah’s Wit-
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Effects of remifentanil on cognitive and
psychomotor functioning and mood
Editor—In this double-blind, placebo-controlled, cross-over
study, we examined the effects of remifentanil on cognitive
and psychomotor function, mood, and subjective feelings, in-
cluding the exploration of gender differences during a steady-
state target-controlled infusion (TCI) of low-dose remifentanil,
which has not been reported before. As a potent, ultra-short-
acting m-opioid receptor agonist remifentanil has a unique
pharmacokinetic profile which makes it an attractive drug for
the study of opioid effects. Our hypothesis was that remifenta-
nil impairs cognitive and psychomotor function and affects




Twenty healthy volunteers (10 men and 10 women) aged
18–40 yr were included. On two testdays, participants received
remifentanil or placebo (saline) in a randomized cross-over de-
sign. Remifentanil was administered at an effect-site concen-
tration of 1 ng ml21 using a TCI pump. The dose was chosen
from previous fMRI studies which showed an analgesic effect
of this dose without excessive sedation or blood oxygen de-
saturation.1 Drug effects were measured using a Digit Symbol
Substitution Task (DSST), choice reaction time (RT), visual
analogue scales (VAS), a Symptom List, and the Profile of
Mood States (POMS) questionnaire (Fig. 1). Data were analysed
using repeated-measures analysis of variance. Differences
with P,0.05 were considered as statistically significant.
Remifentanil slowed down psychomotor function as seen in
a significantly increased RT (401 vs 373 ms), but did not affect
cognitive performance on the DSST. During remifentanil infu-
sion, participants felt more sleepy, confused, dizzy, and had
more itchy skin. Women felt sleepier and tended to feel more
sad and nauseous than men. On the POMS questionnaire, remi-
fentanil increased vigour, fatigue, and feeling confused in both
genders, but had no dysphoric effects on participants.
Since cognitive and psychomotor functioning (e.g. memory,
attention, visuo-motor coordination) are essential during re-
covery from sedation and anaesthesia, knowledge of these
effects for individual drugs is useful for a clinician, for example,
to evaluate the home-readiness of patients. In addition,
remifentanil caused sedation, fatigue, and confusion in partici-
pants, but at the same time, they felt more vigour. Women felt
stronger sedated and had more side-effects than men. Ap-
proximately 30 min after remifentanil infusion as the TCI
reached an effect-site concentration of 0.0 ng ml21, partici-
pants still felt dizzy [VAS score 2.95 (1.0) mm, P¼0.007], but












1 WiseRG,Williams P, Tracey I. UsingfMRI to quantify the time depend-
ence of remifentanil analgesia in the human brain. Neuropsycho-
pharmacology 2004; 29: 626–35
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Fig 1 Overview of test day: 2 test days with placebo or remifentanil infusions, at least 3 days apart, each 3 h in duration. T, time; VAS, visual ana-
logue scale, we used 12 consisting of items related to subjective feelings and adverse effects of the drug; POMS, profile of mood states. The POMS is a
65-item, adjective rating scale designed to measure multiple dimensions of effect. Symptom list consisting of 28 items on a scale of 1 ‘Not at all’ to 5
‘Extremely’. DSST, Digit Symbol Substitution Test, is a subscale of the Wechsler Adult Intelligence Scale and has been used to assess information
processing (attention, working memory, perceptual speed, motor speed, and visuo-motor coordination). RT, the visual choice Reaction Time test10
measures, apart from simple motor performance and speed, eye–hand coordination, attention, and decision-making.
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